QUANTUM DOT-LOADED MESENCHYMAL STEM CELLS FOR TUMOR-TROPIC THERAPY

Dominyka Dapkute1, 2, Simona Steponkiene2, Vytautas Kaseta2, 3, Una Riekstina4, Ricardas Rotomskis2, 5

1 Faculty of Natural Sciences, Vilnius University, Lithuania

2 Laboratory of Biomedical Physics, National Cancer Institute, Vilnius, Lithuania

3 Department of Stem Cell Biology, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania

4 Faculty of Medicine, University of Latvia, Riga, Latvia

5 Biophotonics group of Laser Research Center, Vilnius University, Vilnius, Lithuania

In the past decade, stem cells, especially mesenchymal stem cells (MSCs), have been derived to track down and destroy malignant cells taking advantage of their tumor-tropic property [1]. MSCs are multipotent cells found in almost all adult tissues and have the ability to self-renew and differentiate into various cell types. MSCs are able to escape immune system and migrate to sites of lesions including tumors by using specific receptors and ligands to facilitate trafficking. Therefore, due to their tumoritropic migratory properties, MSCs can be used as delivery systems to transport nanocompounds directly to cancer cells [2].

Quantum dots (QDs) are fluorescent nanoparticles. Due to their unique optical properties and capability to form complexes and conjugates with bioactive molecules they can be used as theranostic nanoplatforms, combining both diagnostics and therapy. Low toxicity, resistance to degradation, long-term photostability and easily modified surface with drugs, photosensitizers or antibodies, enable them to be used as labels and therapeutic agents inside MSCs vehicles [3]. QDs have already been reported to be used for MSCs tracking [4], however the knowledge about QD-loaded migratory capacity of MSCs is still limited.

Before using MSCs as carriers of nanoparticles, optimal conditions for QDs loading in MSCs need to be established. In our study we, firstly, identified human skin-derived MSCs by the expression of specific surface molecules. Then we determined the optimal non-toxic concentration of QDs using cell viability test. Using confocal microscopy we detected rapid uptake of QDs and their localization in vesicles. Flow cytometric analysis showed time-dependent increase of photoluminescence intensity of QDs and the saturation point at 6 hours (Fig. 1). A more detailed analysis revealed correlation between photoluminescence intensity of QDs inside cells and the proliferation marker Ki67.

Figure 1
Fig. 1. Uptake of COOH-625 QDs in MSCs.

In conclusion, we optimized effective QDs concentration for labeling MSCs, found 6 hours incubation time to be sufficient to reach maximum upload of QDs and also revealed proliferation-dependent uptake dynamics.

Acknowledgments: This work was financially supported by the Joint Lithuanian-Latvian-Taiwanese Tripartite Cooperation Programme, Grant No. TAP-LLT-13-016.


[1] L. Linlin, G. Yunqian et al., Silica Nanorattle Doxorubicin-Anchored Mesenchymal Stem Cells for Tumor-Tropic Therapy, ACS Nano 5(9), 7462-7470 (2011).

[2] C. Tang, P.-J. Russel, R. Martiniello-Wilks et al., Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy? Stem Cells 28(9), 1686-1702 (2010).

[3] B.-J. Muller-Borer, M.-C. Collins et al., Quantum dot labeling of mesenchymal stem cells, Journal of Nanobiotechnology 5:9 (2007).

[4] A. Rak-Raszewska, M. Marcello et al., Quantum Dots Do Not Affect the Behaviour of Mouse Embryonic Stem Cells and Kidney Stem Cells and Are Suitable for Short-Term Tracking, PLoS One 7(3), e32650 (2012).